155 related articles for article (PubMed ID: 19736010)
1. Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations.
Collins J; Bove KE; Dimmock D; Morehart P; Wong LJ; Wong B
Neuromuscul Disord; 2009 Nov; 19(11):784-7. PubMed ID: 19736010
[TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.
Götz A; Isohanni P; Pihko H; Paetau A; Herva R; Saarenpää-Heikkilä O; Valanne L; Marjavaara S; Suomalainen A
Brain; 2008 Nov; 131(Pt 11):2841-50. PubMed ID: 18819985
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
[TBL] [Abstract][Full Text] [Related]
4. Reversion of mtDNA depletion in a patient with TK2 deficiency.
Vilà MR; Segovia-Silvestre T; Gámez J; Marina A; Naini AB; Meseguer A; Lombès A; Bonilla E; DiMauro S; Hirano M; Andreu AL
Neurology; 2003 Apr; 60(7):1203-5. PubMed ID: 12682338
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations in the thymidine kinase 2 gene (TK2) associated with fatal mitochondrial myopathy and mitochondrial DNA depletion.
Tulinius M; Moslemi AR; Darin N; Holme E; Oldfors A
Neuromuscul Disord; 2005 Jun; 15(6):412-5. PubMed ID: 15907288
[TBL] [Abstract][Full Text] [Related]
6. A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion.
Leshinsky-Silver E; Michelson M; Cohen S; Ginsberg M; Sadeh M; Barash V; Lerman-Sagie T; Lev D
Eur J Paediatr Neurol; 2008 Jul; 12(4):309-13. PubMed ID: 17951082
[TBL] [Abstract][Full Text] [Related]
7. Late-onset thymidine kinase 2 deficiency: a review of 18 cases.
Domínguez-González C; Hernández-Laín A; Rivas E; Hernández-Voth A; Sayas Catalán J; Fernández-Torrón R; Fuiza-Luces C; García García J; Morís G; Olivé M; Miralles F; Díaz-Manera J; Caballero C; Méndez-Ferrer B; Martí R; García Arumi E; Badosa MC; Esteban J; Jimenez-Mallebrera C; Encinar AB; Arenas J; Hirano M; Martin MÁ; Paradas C
Orphanet J Rare Dis; 2019 May; 14(1):100. PubMed ID: 31060578
[TBL] [Abstract][Full Text] [Related]
8. Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and a novel mutation in the TK2 gene.
Martí R; Nascimento A; Colomer J; Lara MC; López-Gallardo E; Ruiz-Pesini E; Montoya J; Andreu AL; Briones P; Pineda M
Pediatr Res; 2010 Aug; 68(2):151-4. PubMed ID: 20421844
[TBL] [Abstract][Full Text] [Related]
9. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.
Wang L; Limongelli A; Vila MR; Carrara F; Zeviani M; Eriksson S
Mol Genet Metab; 2005 Jan; 84(1):75-82. PubMed ID: 15639197
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations.
Roos S; Lindgren U; Ehrstedt C; Moslemi AR; Oldfors A
Neuromuscul Disord; 2014 Aug; 24(8):713-20. PubMed ID: 24953930
[TBL] [Abstract][Full Text] [Related]
11. Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency.
Vilà MR; Villarroya J; García-Arumí E; Castellote A; Meseguer A; Hirano M; Roig M
J Neurol Sci; 2008 Apr; 267(1-2):137-41. PubMed ID: 18021809
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
Chanprasert S; Wang J; Weng SW; Enns GM; Boué DR; Wong BL; Mendell JR; Perry DA; Sahenk Z; Craigen WJ; Alcala FJ; Pascual JM; Melancon S; Zhang VW; Scaglia F; Wong LJ
Mol Genet Metab; 2013; 110(1-2):153-61. PubMed ID: 23932787
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy.
Blakely E; He L; Gardner JL; Hudson G; Walter J; Hughes I; Turnbull DM; Taylor RW
Neuromuscul Disord; 2008 Jul; 18(7):557-60. PubMed ID: 18508266
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular features of mitochondrial DNA depletion syndromes.
Spinazzola A; Invernizzi F; Carrara F; Lamantea E; Donati A; Dirocco M; Giordano I; Meznaric-Petrusa M; Baruffini E; Ferrero I; Zeviani M
J Inherit Metab Dis; 2009 Apr; 32(2):143-58. PubMed ID: 19125351
[TBL] [Abstract][Full Text] [Related]
15. Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion.
Zhang S; Li FY; Bass HN; Pursley A; Schmitt ES; Brown BL; Brundage EK; Mardach R; Wong LJ
Mol Genet Metab; 2010 Jan; 99(1):53-7. PubMed ID: 19815440
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion.
Nevo Y; Soffer D; Kutai M; Zelnik N; Saada A; Jossiphov J; Messer G; Shaag A; Shahar E; Harel S; Elpeleg O
J Child Neurol; 2002 Jul; 17(7):499-504. PubMed ID: 12269728
[TBL] [Abstract][Full Text] [Related]
17. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum.
Béhin A; Jardel C; Claeys KG; Fagart J; Louha M; Romero NB; Laforêt P; Eymard B; Lombès A
Neurology; 2012 Feb; 78(9):644-8. PubMed ID: 22345218
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA.
Mancuso M; Salviati L; Sacconi S; Otaegui D; Camaño P; Marina A; Bacman S; Moraes CT; Carlo JR; Garcia M; Garcia-Alvarez M; Monzon L; Naini AB; Hirano M; Bonilla E; Taratuto AL; DiMauro S; Vu TH
Neurology; 2002 Oct; 59(8):1197-202. PubMed ID: 12391347
[TBL] [Abstract][Full Text] [Related]
20. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.
Saada A; Shaag A; Mandel H; Nevo Y; Eriksson S; Elpeleg O
Nat Genet; 2001 Nov; 29(3):342-4. PubMed ID: 11687801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
